The pain associated with an injection or minor surgical procedure at a site on the skin of a patient is reduced by urging a skin engaging surface of a pressure member against the skin proximate the site, thereby stimulating the large diameter afferent sensory nerve fibers in the skin proximate the site and at least partially blocking pain signals from the small diameter afferent pain nerve fibers in the skin proximate the site. An apparatus for use in this method comprises a pressure member having a skin engaging surface adapted to be pressed against the skin of a patient proximate the site to stimulate the large diameter afferent sensory nerve fibers in the skin proximate the site. In certain embodiments, the skin engaging surface is comprised of a plurality of projections extending from the pressure member. Various embodiments include a syringe retainer adapted to be secured to a syringe, and a least one resilient member, such as a spring, resiliently securing the pressure member to the syringe retainer.
|
1. A method for reducing the pain associated with penetration of the skin of a patient at a site with a needle or surgical instrument, comprising providing a pressure member having a generally flat disk shape and being relatively broad in relation to the thickness of the pressure member, the pressure member having a skin engaging surface comprised of a plurality of projections extending from said pressure member, wherein the disc completely encircles the penetration site and urging the skin engaging surface of the pressure member against the skin of a patient proximate the site, to thereby depress the skin with sufficient force to stimulate the large diameter afferent sensory nerve fibers in the skin proximate the site and at least partially block pain signals from the small diameter afferent pain nerve fibers in the skin proximate the site.
2. The method of
3. The method of
4. The method of
7. The method of
8. The method of
9. The method of
10. The method of
11. The method of
13. The method of
|
This application is claiming the benefit, under 35 U.S.C. § 119(e), of the provisional application filed Jul. 31, 2000 under 35 U.S.C. § 111(b), which was granted Ser. No. 60/221,906, and the provisional application filed Jan. 4, 2001 under 35 U.S.C. § 111(b), which was granted Ser. No. 60/259,788. Both provisional applications are hereby incorporated by reference.
The invention relates to a method of reducing or eliminating the pain from injections or minor surgical procedures by the local application of pressure about the injection or surgical site to block afferent pain fiber transmission. The invention further relates to devices that can be used to apply local pressure to an injection or surgical site to reduce or eliminate the pain associated therewith.
The pain elicited by administering minor injections, such as those with childhood immunizations, is a significant cause of stress in the medical office. It causes fear and anxiety in patients both young and old. It can create difficulties in developing patient rapport and confidence, and can even impair the physician's ability to perform an examination because of a patient's overriding preoccupation with the forthcoming shot or procedure. Any procedure and/or device that diminishes the pain associated with simple injections or minor surgical procedures would be of great help.
Such a procedure and/or device could be especially useful, as another example, to those with diabetes. Diabetes is a common disorder of the endocrine system affecting millions of individuals worldwide. In diabetes, the body loses its ability to manufacture insulin, a hormone produced normally in the islets cells of the pancreas. Insulin has many functions, but its primary function is to promote glucose uptake from the blood into the cells of the body where it can be metabolized to provide energy for those cells. In diabetes, the lack of insulin causes blood sugar to rise to dangerously high levels, causing dehydration and possible brain injury. At the same time, cells starved for glucose turn to fat metabolism for energy production, causing ketonemia and life threatening acidosis.
This severe disruption of the body's physiology and many of the later sequellae of diabetes can be avoided by giving insulin to diabetic patients. However, because insulin is a protein, the only currently available forms of the hormone must be given via injection. The sites chosen are usually the thigh and the abdomen, and diabetic patients often must take multiple injections of insulin daily. Newer treatment protocols advocate even tighter control involving six or more injections daily.
The pain elicited by chronic insulin injections is a constant source of anxiety and stress to the diabetic patient. Even when resigned to a lifetime of insulin injections, the pain associated with daily insulin shots is never appreciated. In fact, in some cases such pain can keep the diabetic patient from following a more aggressive insulin protocol just so he/she can avoid the increased number of injections. It will be appreciated that any device and/or procedure that diminishes the pain associated with daily insulin injections would be of great help.
Current studies have supported the gate control theory of pain awareness and transmission. Briefly stated, pain is elicited when noxious stimuli trigger nociceptive nerve endings in the skin. Pain impulses are then transmitted by small diameter peripheral afferent fibers through the spinal cord to the brain. Gate theory states that there is a gating mechanism in the dorsal horn of the spinal cord that acts to facilitate or inhibit transmission of pain signals to the brain. Stimulation of the small diameter nociceptive (pain) fibers opens the gate. The gate can be closed by simultaneous stimulation of large diameter afferent sensory nerve fibers, such as those that respond to mechanical stimuli such as touch and vibration.
Although gate control theory probably oversimplifies the true complexity of the body's regulation of pain, it has proved to be a useful guide to understanding and predicting pain and its control. Practical application of gate control theory has led to the development and widespread use of TENS units. TENS, transcutaneous electrical nerve stimulation, stimulates large diameter afferent sensory fibers with repetitive electrical impulses to use gate control to block pain signals from small diameter afferent pain nerve fibers. In many individuals with chronic pain TENS units employing the gate control theory of pain management provide significant and predictable relief from their pain.
Anecdotal experience by physicians has shown that the local application of pressure can reduce the pain from simple injections. A recent study was performed that documented and quantified this ability of simple applied finger pressure to reduce needle pain. These findings, reported in the Journal of Pain and Symptom Management, Vol. 12, No. 1, July 1996, pp. 52-58, support gate control theory and provide evidence that mechanical pressure can directly affect a person's sensation of pain.
The invention is directed to a method of reducing or eliminating the pain from injections or minor surgical procedures by the local application of pressure about the injection or surgical site to block afferent pain fiber transmission. Such minor surgical procedures might include, as examples, small shave or punch biopsies, the freezing of warts, and procedures involving needle electrodes. The invention further relates to devices that can be used to apply local pressure to an injection or surgical site to reduce or eliminate the pain associated therewith.
The method of the invention reduces the pain associated with penetration of the skin of a patient at a site with a needle or surgical instrument by urging a skin engaging surface of a pressure member against the skin of a patient at the site. This stimulates the large diameter afferent sensory nerve fibers in the skin proximate the site and at least partially blocks pain signals from the small diameter afferent pain nerve fibers in the same area. By penetration of the skin, as used herein, it is meant penetration of at least an outer layer of the skin by a needle or surgical instrument.
An apparatus in accordance with the invention comprises a pressure member having a skin engaging surface adapted to be pressed against the skin of a patient at the site to stimulate the large diameter afferent sensory nerve fibers in the skin proximate the site and at least partially block pain signals from the small diameter afferent pain nerve fibers in the skin proximate that site. In certain embodiments of the invention, the skin engaging surface is comprised of a plurality of projections extending from the pressure member. It is believed that such a plurality of projections promotes blocking of pain signals from the small diameter afferent pain nerve fibers in the skin proximate the site.
The pressure member of the apparatus of the invention may have an aperture about which the skin engaging surface extends. Such an aperture is aligned with the injection or surgical site, and the needle or surgical instrument is introduced through the aperture to penetrate the skin. Such a structure permits the skin engaging surface of the pressure member to substantially surround the site in a manner believed to promote the blocking of pain signals from the small diameter afferent pain nerve fibers in the skin proximate the site.
In various embodiments of the invention, an apparatus for reducing the pain associated with the penetration of the skin of a patient at a site with a needle or surgical instrument is provided that comprises a pressure member having a slot adapted to receive the needle or surgical instrument. Such a slot may be aligned, for example, with a patient's blood vessel during a procedure to draw blood from the patient or for the insertion of an IV catheter. In such cases, the slot may extend to the perimeter of the pressure member, so that the pressure member does not occlude the vessel ahead of the site of the procedure.
In other embodiments related to the use of the invention specifically with injections from a hypodermic needle, the apparatus of the invention is comprised of a pressure member having a skin engaging surface and a syringe retainer adapted to be secured to a syringe. At least one spring resiliently secures the pressure member to the syringe retainer. The spring is adapted to be compressed under the force used to administer an injection to a patient, allowing a reduction in the distance between the pressure member and the syringe retainer so that the needle can penetrate the skin at the site.
The advantages of the invention will become readily apparent to those skilled in the art from the following detailed description of various embodiments when considered in the light of the accompanying drawings, in which:
It is to be understood that the specific devices and processes illustrated in the attached drawings and described in the following description are simply exemplary embodiments of the inventive concepts defined in the appended claims. Hence, specific dimensions and other physical characteristics relating to the embodiments disclosed herein should not be considered as limiting, unless the claims expressly state otherwise.
Referring now to the drawings,
It will be understood that in practice projections having a number of shapes and configurations will provide adequate sensory and pressure nerve stimulation and thus will be efficacious in this application and may be substituted for the substantially conical and frustoconical shapes illustrated. In general, it will be preferred that the ends of the projections be blunt relative to the end of the needle or surgical instrument being used.
An aperture 30 is provided in the pressure member 22 to allow a nurse or physician to administer the injection or access the surgical site once the device has been applied to the skin. As shown in
As an alternative to providing an aperture, the pressure member in the various embodiments of the invention could be formed out of material, such as a silicone rubber sheet, that allows a needle to pass through at any point, obviating the need for an opening. Finger needle guards (not shown) could also be provided for extra operator safety.
The peripheral edge 34 of the pressure member 22 may be configured, as illustrated in
The apparatus of the invention, in its various embodiments, may be formed of any suitable material or combination of materials. The material forming the pressure member is preferably flexible enough to substantially conform to the contours of the skin in the vicinity of the injection or surgical site as the pressure member is forced against the skin. This allows for the application of a greater number of the projections to the skin of the patient proximate the site. The material forming the pressure member and projections is preferably sufficiently stiff that relatively equal pressure is provided to the skin from the plurality of projections. Polymeric materials such as polyethylene are suitable. The entire apparatus may be molded as an integral part from a polymeric material such as polyethylene. In certain applications, it may be an advantage to form the pressure member of a relatively stiff material, such as a rigid metal.
As illustrated in
An aperture 58 is provided in the pressure member 54 to allow for the administration of an injection or to allow access the surgical site once the apparatus 52 has been applied to the skin of a patient. As shown in
The embodiment 62 shown in
The peripheral edge 72 of the pressure member 64 may be configured so as to have at least one noncircular section to facilitate handling of the pressure member. In the embodiment of
The pressure member 76 is a relatively thin, generally flat disk that has a skin engaging surface on its underside formed by the ends of a plurality of projections 82. In addition, the peripheral edge 80 of the pressure member 76 has been configured so as to have at least one noncircular section to facilitate handling of the pressure member. Thus, the peripheral edge 80 is scalloped, giving the apparatus a generally cloverleaf shape. The peripheral edge 80 has also been formed of a thickness greater than the thickness of the more central portions of the pressure member 76, thereby defining a raised lip about the periphery of the pressure member.
Thus, in accordance with various embodiments of the method of the invention, the pain associated with penetration of the skin of a patient at a site with a needle or surgical instrument is reduced by urging a skin engaging surface of a pressure member against the skin of a patient at the site. The pressure applied by the skin engaging surface stimulates the large diameter afferent sensory nerve fibers in the skin proximate the site, at least partially blocking pain signals from the small diameter afferent pain nerve fibers in the skin proximate the site.
The peripheral edge of the apparatus is readily gripped in the hand of a user. The apparatus is then manipulated so as to urge the skin engaging surface of the pressure member against the skin of the patient proximate the injection or surgical site. Where an aperture is provided in the pressure member, the aperture is aligned with the desired injection or surgical site. Where a slot is provided in the pressure member, the slot may, as an example, be aligned with a desired blood vessel.
When the skin engaging surface of the pressure member is urged against the skin of the patient with sufficient force, the skin is depressed and the pressure sensory nerves located in the skin proximate the site are stimulated. Nerve impulses from these fibers flood the dorsal horn gate and inhibit the transmission of pain nerve impulses from the same area. The pressure is applied to the skin through the skin engaging surface of the pressure member in such a manner that the nerve impulses from the large fiber nerves reach the dorsal horn gate prior to the nerve impulses from the small fiber nerves stimulated by penetration of the needle or surgical instrument.
This generally means that the skin engaging surface contacts the skin proximate the site at a time just slightly before the needle or surgical instrument contacts the skin at the site. The pressure exerted against the skin by the skin engaging surface of the pressure member may be maintained until the injection or minor surgical procedure has been completed. If the pressure is applied too far in advance of the injection or surgical procedure, the large diameter afferent sensory nerve fibers will have a chance to repolarize and stop sending signals down the afferent pathway. This would allow the gate to open in response to pain nerve fiber impulses and again allow the patient to perceive the painful stimulus.
The invention thus provides a method of reducing or eliminating the pain from injections or simple surgical procedures by the local application of pressure circumferential to the injection or surgical site, thus blocking afferent pain fiber transmission by application of gate theory. Various embodiments of an apparatus of the invention produces non-noxious mechanical pressure in the local area of the injection or surgical site in order to stimulate large diameter afferent sensory nerve fibers to block the co-incident transmission of pain fiber impulses through practical application of gate theory. In this manner, the pain from injections, such as those associated with immunizations or insulin shots, and minor surgical procedures might be mitigated significantly.
A further apparatus 84 in accordance with the invention is illustrated in
As illustrated, the skin engaging surface 88 is formed by the ends of a plurality of projections 90 that are spaced about and extend from the underside of the pressure member 86. The projections 88 in this embodiment are shown as being substantially conical in shape with rounded ends. A number of shapes and configurations will provide adequate sensory and pressure nerve stimulation and thus will be efficacious in this application and may be substituted for the shape shown.
An aperture 92 is provided in the pressure member 86 to allow for the introduction of the needle of a hypodermic syringe (not shown) once the apparatus has been applied to the skin. As shown in
The apparatus 84 further includes a syringe retainer 94 adapted to be secured to a syringe. The syringe retainer 94 is annular in shape, being provided with a central bore 96 adapted to receive the barrel of the syringe in a friction fit. The bore 96 includes a reduced diameter lower portion 98 that allows for the passage of the needle, while defining a step 100 that abuts a portion of the syringe, thereby preventing axial movement of the syringe relative to the syringe retainer 94 in the direction of the pressure member 86.
The syringe retainer 94 is resiliently connected to the pressure member 86 by one or more resilient members, such as the spring 102. It will be understood that other types of resilient, compressible structures may function as well to provide the necessary tension for the device and may be substituted for the helical spring mechanism shown in the drawings. The spring 102 as shown has two helical segments 104. The spring 102 is adapted to be compressed under the force used to administer an injection to a patient, allowing the pressure member 86 and the syringe retainer 94 to move towards each other in a linear fashion so that the needle penetrates the skin at the injection site. The spring 102 or other resilient, compressible structure provides enough resistance to movement of the pressure member 86 relative to the syringe retainer 94 that, when the pressure member 86 contacts the skin, the projections 90 depress the skin with sufficient force to stimulate the large diameter afferent sensory nerve fibers.
The apparatus 84 of the invention may be formed of any suitable material or combination of materials. Polymeric materials such as polyethylene are especially suitable. Multiple portions or the entire apparatus 84 may be molded as an integral part from a polymeric material such as polyethylene.
In accordance with the provisions of the patent statutes, the invention has been described in what is considered to represent its preferred embodiments. However, it should be noted that the invention can be practiced otherwise than as specifically illustrated and described without departing from its spirit or scope. As an example, it will be appreciated that, in those embodiments in which the apparatus includes a plurality of projections, the size and shape of the projections may vary considerably.
Patent | Priority | Assignee | Title |
10016229, | Mar 15 2013 | PACIRA CRYOTECH, INC | Methods and systems for treatment of occipital neuralgia |
10085789, | Mar 15 2013 | PACIRA CRYOTECH, INC | Methods and systems for treatment of occipital neuralgia |
10085881, | Mar 15 2013 | PACIRA CRYOTECH, INC | Methods, systems, and devices for treating neuromas, fibromas, nerve entrapment, and/or pain associated therewith |
10130409, | Nov 05 2013 | PACIRA CRYOTECH, INC | Secure cryosurgical treatment system |
10188444, | Jan 13 2012 | PACIRA CRYOTECH, INC | Skin protection for subdermal cryogenic remodeling for cosmetic and other treatments |
10213244, | Jan 13 2012 | PACIRA CRYOTECH, INC | Cryogenic needle with freeze zone regulation |
10220122, | Dec 22 2010 | Ulthera, Inc. | System for tissue dissection and aspiration |
10226586, | May 26 2011 | Means and method to painlessly puncture skin | |
10271866, | Aug 07 2009 | Ulthera, Inc. | Modular systems for treating tissue |
10314739, | Mar 15 2013 | PACIRA CRYOTECH, INC | Methods and devices for pain management |
10363080, | May 20 2005 | PACIRA CRYOTECH, INC | Subdermal cryogenic remodeling of muscles, nerves, connective tissue, and/or adipose tissue (fat) |
10470698, | Nov 30 2011 | Lincoln Diagnostics, Inc. | Allergy testing device and method of testing for allergies |
10485573, | Aug 07 2009 | Ulthera, Inc. | Handpieces for tissue treatment |
10531888, | Aug 07 2009 | Ulthera, Inc. | Methods for efficiently reducing the appearance of cellulite |
10548659, | Jan 07 2006 | ULTHERA, INC | High pressure pre-burst for improved fluid delivery |
10596030, | Mar 15 2013 | PACIRA CRYOTECH, INC | Cryogenic enhancement of joint function, alleviation of joint stiffness and/or alleviation of pain associated with osteoarthritis |
10603066, | May 25 2010 | Ulthera, Inc. | Fluid-jet dissection system and method for reducing the appearance of cellulite |
10653354, | Mar 15 2013 | Ohio State Innovation Foundation | Medical testing apparatus and method of use |
10864033, | Nov 05 2013 | PACIRA CRYOTECH, INC | Secure cryosurgical treatment system |
10864112, | Nov 14 2007 | Pacira CryoTech, Inc. | Pain management using cryogenic remodeling |
10869779, | Nov 14 2007 | Pacira CryoTech, Inc. | Pain management using cryogenic remodeling |
10888366, | Mar 15 2013 | PACIRA CRYOTECH, INC | Cryogenic blunt dissection methods and devices |
10933199, | Nov 12 2009 | Means and method to give injections with little or no pain | |
10939947, | Dec 21 2006 | PACIRA CRYOTECH, INC | Dermal and transdermal cryogenic microprobe systems |
10973994, | Sep 16 2013 | Means and method to invade skin, mucosa, and underlying tissues with little or no pain | |
11039823, | May 03 2017 | Z Surgical LLC | Minimal-access percutaneous and self-retracting surgical system |
11096708, | Aug 07 2009 | Ulthera, Inc. | Devices and methods for performing subcutaneous surgery |
11134998, | Nov 15 2017 | PACIRA CRYOTECH, INC | Integrated cold therapy and electrical stimulation systems for locating and treating nerves and associated methods |
11134999, | Mar 15 2013 | PACIRA CRYOTECH, INC | Methods and systems for treatment of occipital neuralgia |
11213618, | Dec 22 2010 | Ulthera, Inc. | System for tissue dissection and aspiration |
11253393, | Mar 15 2013 | PACIRA CRYOTECH, INC | Methods, systems, and devices for treating neuromas, fibromas, nerve entrapment, and/or pain associated therewith |
11311327, | May 13 2016 | PACIRA CRYOTECH, INC | Methods and systems for locating and treating nerves with cold therapy |
11337725, | Aug 07 2009 | Ulthera, Inc. | Handpieces for tissue treatment |
11350979, | May 20 2005 | Pacira CryoTech, Inc. | Subdermal cryogenic remodeling of muscles, nerves, connective tissue, and/or adipose tissue (fat) |
11471615, | Dec 15 2018 | Device for assisting subcutaneous injections | |
11529092, | Nov 30 2011 | Lincoln Diagnostics, Inc. | Allergy testing device and method of testing for allergies |
11642241, | Mar 15 2013 | Pacira CryoTech, Inc. | Cryogenic enhancement of joint function, alleviation of joint stiffness and/or alleviation of pain associated with osteoarthritis |
11672694, | Nov 14 2007 | PACIRA CRYOTECH, INC | Pain management using cryogenic remodeling |
11690661, | Nov 05 2013 | Pacira CryoTech, Inc. | Secure cryosurgical treatment system |
11857239, | Jan 13 2012 | PACIRA CRYOTECH, INC | Cryogenic needle with freeze zone regulation |
11865038, | Mar 15 2013 | Pacira CryoTech, Inc. | Methods, systems, and devices for treating nerve spasticity |
7842007, | Apr 30 2004 | Apparatus and methods for isolating human body areas for localized cooling | |
7935139, | Dec 10 2001 | Candela Corporation | Eye safe dermatological phototherapy |
8121696, | Feb 02 2007 | Innova Medical Design, LLC | Topical analgesia using electrical and vibration stimuli |
8372103, | Jan 12 2006 | Owen Mumford, Ltd. | Lancet firing device |
8506506, | Jan 12 2009 | Solta Medical, Inc. | Tissue treatment apparatus with functional mechanical stimulation and methods for reducing pain during tissue treatments |
8788060, | Jul 16 2009 | Solta Medical, Inc. | Tissue treatment systems with high powered functional electrical stimulation and methods for reducing pain during tissue treatments |
8882758, | Jan 09 2009 | Solta Medical, Inc. | Tissue treatment apparatus and systems with pain mitigation and methods for mitigating pain during tissue treatments |
8905971, | Dec 02 2005 | Owen Mumford, Ltd. | Injection method and apparatus |
8998855, | Nov 17 2008 | Owen Mumford Limited | Syringe and needle cover remover |
9017318, | Jan 20 2012 | PACIRA CRYOTECH, INC | Cryogenic probe system and method |
9066712, | Dec 22 2008 | PACIRA CRYOTECH, INC | Integrated cryosurgical system with refrigerant and electrical power source |
9072498, | May 20 2005 | PACIRA CRYOTECH, INC | Subdermal cryogenic remodeling of muscles, nerves, connective tissue, and/or adipose tissue (fat) |
9101346, | Nov 14 2007 | PACIRA CRYOTECH, INC | Pain management using cryogenic remodeling |
9113855, | Feb 16 2007 | PACIRA CRYOTECH, INC | Replaceable and/or easily removable needle systems for dermal and transdermal cryogenic remodeling |
9155584, | Jan 13 2012 | PACIRA CRYOTECH, INC | Cryogenic probe filtration system |
9241753, | Jan 13 2012 | PACIRA CRYOTECH, INC | Skin protection for subdermal cryogenic remodeling for cosmetic and other treatments |
9254162, | Dec 21 2006 | PACIRA CRYOTECH, INC | Dermal and transdermal cryogenic microprobe systems |
9272124, | Dec 02 2005 | Ulthera, Inc. | Systems and devices for selective cell lysis and methods of using same |
9295512, | Mar 15 2013 | PACIRA CRYOTECH, INC | Methods and devices for pain management |
9314290, | Jan 13 2012 | PACIRA CRYOTECH, INC | Cryogenic needle with freeze zone regulation |
9345526, | May 20 2005 | PACIRA CRYOTECH, INC | Subdermal cryogenic remodeling of muscles, nerves, connective tissue, and/or adipose tissue (fat) |
9358033, | May 25 2010 | ULTHERA, INC | Fluid-jet dissection system and method for reducing the appearance of cellulite |
9358064, | Aug 07 2009 | CABOCHON AESTHETICS, INC | Handpiece and methods for performing subcutaneous surgery |
9364246, | Aug 07 2009 | ULTHERA, INC | Dissection handpiece and method for reducing the appearance of cellulite |
9364287, | Jun 05 2007 | SOLTA MEDICAL, INC | Method for reducing pain of dermatological treatments |
9510849, | Aug 07 2009 | Ulthera, Inc. | Devices and methods for performing subcutaneous surgery |
9610112, | Mar 15 2013 | PACIRA CRYOTECH, INC | Cryogenic enhancement of joint function, alleviation of joint stiffness and/or alleviation of pain associated with osteoarthritis |
9668800, | Mar 15 2013 | PACIRA CRYOTECH, INC | Methods and systems for treatment of spasticity |
9757145, | Aug 07 2009 | Ulthera, Inc. | Dissection handpiece and method for reducing the appearance of cellulite |
9770560, | Nov 12 2009 | Means and method to administer injections with little or no pain | |
9907693, | Nov 14 2007 | PACIRA CRYOTECH, INC | Pain management using cryogenic remodeling |
D539426, | Oct 28 2005 | Veteren Medical Products, Inc. | Ear curette |
ER8355, |
Patent | Priority | Assignee | Title |
3620209, | |||
5364362, | Feb 19 1992 | Henke-Sass, Wolf GmbH | Front syringe attachment for hypodermic syringes for subcutaneous injection in veterinary medicine |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Jul 27 2001 | HUTTNER, JAMES J | Bionix Development Corporation | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 012054 | /0717 | |
Jul 31 2001 | Bionix Development Corporation | (assignment on the face of the patent) | / | |||
Dec 30 2020 | BIONIX HEALTH AT HOME LLC | Bionix, LLC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 054801 | /0832 | |
Dec 30 2020 | BIONIX MEDICAL TECHNOLOGIES, LLC | Bionix, LLC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 054801 | /0832 | |
Dec 30 2020 | BIONIX SAFETY TECHNOLOGIES, LTD | Bionix, LLC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 054801 | /0832 | |
Dec 30 2020 | Bionix Development Corporation | Bionix, LLC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 054801 | /0832 | |
Dec 30 2020 | BIONIX APPLIED RESEARCH, LLC | Bionix, LLC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 054801 | /0832 | |
Dec 30 2020 | Bionix Prosthetic Solutions, LLC | Bionix, LLC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 054801 | /0832 | |
Dec 30 2020 | DELTA CARE, LLC | Bionix, LLC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 054801 | /0832 | |
Dec 30 2020 | UPSTAIRS MEDICAL, LLC | Bionix, LLC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 054801 | /0832 | |
Dec 30 2020 | SENSIS MEDICAL LLC | Bionix, LLC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 054801 | /0832 |
Date | Maintenance Fee Events |
Jul 02 2008 | M2551: Payment of Maintenance Fee, 4th Yr, Small Entity. |
Jun 25 2012 | M2552: Payment of Maintenance Fee, 8th Yr, Small Entity. |
Jun 21 2016 | M2553: Payment of Maintenance Fee, 12th Yr, Small Entity. |
Date | Maintenance Schedule |
Jun 07 2008 | 4 years fee payment window open |
Dec 07 2008 | 6 months grace period start (w surcharge) |
Jun 07 2009 | patent expiry (for year 4) |
Jun 07 2011 | 2 years to revive unintentionally abandoned end. (for year 4) |
Jun 07 2012 | 8 years fee payment window open |
Dec 07 2012 | 6 months grace period start (w surcharge) |
Jun 07 2013 | patent expiry (for year 8) |
Jun 07 2015 | 2 years to revive unintentionally abandoned end. (for year 8) |
Jun 07 2016 | 12 years fee payment window open |
Dec 07 2016 | 6 months grace period start (w surcharge) |
Jun 07 2017 | patent expiry (for year 12) |
Jun 07 2019 | 2 years to revive unintentionally abandoned end. (for year 12) |